Pfizer Is Worst-Performing US Large-Cap Pharma Stock This Year, Its Investment Case Is Complex Yet Rewarding
November 18, 2022 at 15:00 PM EST
Credit Suisse has initiated coverage onPfizer Inc(NYSE: PFE) with an Outperform rating and aprice target of ...